These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
304 related articles for article (PubMed ID: 21699084)
1. Inhibition of thioredoxin reductase by auranofin induces apoptosis in adriamycin-resistant human K562 chronic myeloid leukemia cells. Liu JJ; Liu Q; Wei HL; Yi J; Zhao HS; Gao LP Pharmazie; 2011 Jun; 66(6):440-4. PubMed ID: 21699084 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of thioredoxin reductase by auranofin induces apoptosis in cisplatin-resistant human ovarian cancer cells. Marzano C; Gandin V; Folda A; Scutari G; Bindoli A; Rigobello MP Free Radic Biol Med; 2007 Mar; 42(6):872-81. PubMed ID: 17320769 [TBL] [Abstract][Full Text] [Related]
3. Auranofin, an inhibitor of thioredoxin reductase, induces apoptosis in hepatocellular carcinoma Hep3B cells by generation of reactive oxygen species. Hwang-Bo H; Jeong JW; Han MH; Park C; Hong SH; Kim GY; Moon SK; Cheong J; Kim WJ; Yoo YH; Choi YH Gen Physiol Biophys; 2017 Apr; 36(2):117-128. PubMed ID: 28218611 [TBL] [Abstract][Full Text] [Related]
4. Cross-talk between two antioxidants, thioredoxin reductase and heme oxygenase-1, and therapeutic implications for multiple myeloma. Raninga PV; Di Trapani G; Vuckovic S; Tonissen KF Redox Biol; 2016 Aug; 8():175-85. PubMed ID: 26795735 [TBL] [Abstract][Full Text] [Related]
6. Acquired multidrug resistance in human K562/ADM cells is associated with enhanced autophagy. Cheng J; Chen J; Xie B; Wei HL Toxicol Mech Methods; 2013 Nov; 23(9):678-83. PubMed ID: 24024664 [TBL] [Abstract][Full Text] [Related]
7. Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase. Gandin V; Fernandes AP; Rigobello MP; Dani B; Sorrentino F; Tisato F; Björnstedt M; Bindoli A; Sturaro A; Rella R; Marzano C Biochem Pharmacol; 2010 Jan; 79(2):90-101. PubMed ID: 19665452 [TBL] [Abstract][Full Text] [Related]
8. [Role of high mobility group box 1 in adriamycin-induced apoptosis in leukemia K562 cells]. Yu Y; Xie M; He YL; Xu WQ; Zhu S; Cao LZ Ai Zheng; 2008 Sep; 27(9):929-33. PubMed ID: 18799030 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of the Nrf2-TrxR Axis Sensitizes the Drug-Resistant Chronic Myelogenous Leukemia Cell Line K562/G01 to Imatinib Treatments. Xu L; Zhao Y; Pan F; Zhu M; Yao L; Liu Y; Feng J; Xiong J; Chen X; Ren F; Tan Y; Wang H Biomed Res Int; 2019; 2019():6502793. PubMed ID: 31828114 [TBL] [Abstract][Full Text] [Related]
10. The thioredoxin reductase inhibitor auranofin triggers apoptosis through a Bax/Bak-dependent process that involves peroxiredoxin 3 oxidation. Cox AG; Brown KK; Arner ES; Hampton MB Biochem Pharmacol; 2008 Oct; 76(9):1097-109. PubMed ID: 18789312 [TBL] [Abstract][Full Text] [Related]
11. Reversal effect of a macrocyclic bisbibenzyl plagiochin E on multidrug resistance in adriamycin-resistant K562/A02 cells. Shi YQ; Qu XJ; Liao YX; Xie CF; Cheng YN; Li S; Lou HX Eur J Pharmacol; 2008 Apr; 584(1):66-71. PubMed ID: 18304528 [TBL] [Abstract][Full Text] [Related]
12. Selenite-induced apoptosis in doxorubicin-resistant cells and effects on the thioredoxin system. Jönsson-Videsäter K; Björkhem-Bergman L; Hossain A; Söderberg A; Eriksson LC; Paul C; Rosén A; Björnstedt M Biochem Pharmacol; 2004 Feb; 67(3):513-22. PubMed ID: 15037203 [TBL] [Abstract][Full Text] [Related]
13. Reversal of P-glycoprotein-mediated multidrug resistance by guggulsterone in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells. Xu HB; Li L; Liu GQ Pharmazie; 2009 Oct; 64(10):660-5. PubMed ID: 19947169 [TBL] [Abstract][Full Text] [Related]
14. Thioredoxin-mimetic peptides (TXM) reverse auranofin induced apoptosis and restore insulin secretion in insulinoma cells. Cohen-Kutner M; Khomsky L; Trus M; Aisner Y; Niv MY; Benhar M; Atlas D Biochem Pharmacol; 2013 Apr; 85(7):977-90. PubMed ID: 23327993 [TBL] [Abstract][Full Text] [Related]
15. Selective inhibition of endogenous antioxidants with Auranofin causes mitochondrial oxidative stress which can be countered by selenium supplementation. Radenkovic F; Holland O; Vanderlelie JJ; Perkins AV Biochem Pharmacol; 2017 Dec; 146():42-52. PubMed ID: 28947276 [TBL] [Abstract][Full Text] [Related]
16. CXCL12/CXCR4 axis confers adriamycin resistance to human chronic myelogenous leukemia and oroxylin A improves the sensitivity of K562/ADM cells. Wang Y; Miao H; Li W; Yao J; Sun Y; Li Z; Zhao L; Guo Q Biochem Pharmacol; 2014 Aug; 90(3):212-25. PubMed ID: 24858801 [TBL] [Abstract][Full Text] [Related]
17. Reductive activation of ricin and ricin A-chain immunotoxins by protein disulfide isomerase and thioredoxin reductase. Bellisola G; Fracasso G; Ippoliti R; Menestrina G; Rosén A; Soldà S; Udali S; Tomazzolli R; Tridente G; Colombatti M Biochem Pharmacol; 2004 May; 67(9):1721-31. PubMed ID: 15081871 [TBL] [Abstract][Full Text] [Related]
19. EM23, a natural sesquiterpene lactone, targets thioredoxin reductase to activate JNK and cell death pathways in human cervical cancer cells. Shao FY; Wang S; Li HY; Chen WB; Wang GC; Ma DL; Wong NS; Xiao H; Liu QY; Zhou GX; Li YL; Li MM; Wang YF; Liu Z Oncotarget; 2016 Feb; 7(6):6790-808. PubMed ID: 26758418 [TBL] [Abstract][Full Text] [Related]
20. Sublethal concentrations of diverse gold compounds inhibit mammalian cytosolic thioredoxin reductase (TrxR1). Omata Y; Folan M; Shaw M; Messer RL; Lockwood PE; Hobbs D; Bouillaguet S; Sano H; Lewis JB; Wataha JC Toxicol In Vitro; 2006 Sep; 20(6):882-90. PubMed ID: 16510263 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]